tyrphostin a23 has been researched along with Sarcoma, Synovial in 1 studies
tyrphostin A23: inhibits EGF-stimulated thymidine incorporation as well as EGF-stimulated receptor autophosphorylation & tyrosine phosphorylation & cell proliferation; structure given in first source
Sarcoma, Synovial: A malignant neoplasm arising from tenosynovial tissue of the joints and in synovial cells of tendons and bursae. The legs are the most common site, but the tumor can occur in the abdominal wall and other trunk muscles. There are two recognized types: the monophasic (characterized by sheaths of monotonous spindle cells) and the biphasic (characterized by slit-like spaces or clefts within the tumor, lined by cuboidal or tall columnar epithelial cells). These sarcomas occur most commonly in the second and fourth decades of life. (From Dorland, 27th ed; DeVita Jr et al., Cancer: Principles & Practice of Oncology, 3d ed, p1363)
Excerpt | Relevance | Reference |
---|---|---|
"Synovial sarcoma is a soft tissue cancer associated with a recurrent t(X:18) translocation that generates one of two fusion proteins, SYT-SSX1 or SYT-SSX2." | 1.34 | The synovial sarcoma SYT-SSX2 oncogene remodels the cytoskeleton through activation of the ephrin pathway. ( Barco, R; Benesh, A; Caldwell, RL; Eid, JE; Frump, AL; Garcia, CB; Hunt, LB, 2007) |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Barco, R | 1 |
Hunt, LB | 1 |
Frump, AL | 1 |
Garcia, CB | 1 |
Benesh, A | 1 |
Caldwell, RL | 1 |
Eid, JE | 1 |
1 other study available for tyrphostin a23 and Sarcoma, Synovial
Article | Year |
---|---|
The synovial sarcoma SYT-SSX2 oncogene remodels the cytoskeleton through activation of the ephrin pathway.
Topics: Animals; Cell Proliferation; Cell Shape; Cytoskeleton; Enzyme Activation; Ephrins; Gene Expression R | 2007 |